Evidence map›Paper›PMID 40699129›Full record

ArticleActa cirurgica brasileira2025

Application of double filtration plasmapheresis to cynomolgus monkeys: surgical techniques and a pilot study of pig fetal kidney transplantation.

Genki Watanabe, Maiko Horikawa, Izumi Yamamoto, Tomohisa Endo, Takashi Watanabe, Akinori Hiratsuka, Tsuyoshi Takamura, Kenji Matsui, Naoto Matsumoto, Yatsumu Saito and 6 more

Abstract read
In one paragraph

Article in Acta cirurgica brasileira, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Genki WatanabeThe Jikei University School of Medicine - Department of Clinical Engineer - Tokyo - Japan.ORCID http://orcid.org/0009-0008-2488-5719
Maiko HorikawaThe Jikei University School of Medicine - Department of Clinical Engineer - Tokyo - Japan.ORCID http://orcid.org/0009-0005-1125-0384
Izumi YamamotoThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0002-9856-0852
Tomohisa EndoThe Jikei University School of Medicine - Department of Clinical Engineer - Tokyo - Japan.ORCID http://orcid.org/0009-0002-4361-649X
Takashi WatanabeThe Jikei University School of Medicine - Department of Clinical Engineer - Tokyo - Japan.ORCID http://orcid.org/0009-0000-8431-141X
Akinori HiratsukaThe Jikei University School of Medicine - Department of Clinical Engineer - Tokyo - Japan.ORCID http://orcid.org/0009-0007-1241-2765
Tsuyoshi TakamuraThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0001-8128-4006
Kenji MatsuiThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0003-2897-2285
Naoto MatsumotoThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0002-2498-8055
Yatsumu SaitoThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0003-3094-9527
Hiroshi SasakiThe Jikei University School of Medicine - Department of Urology - Tokyo - Japan.ORCID http://orcid.org/0000-0001-7934-9923
Akihiko KiyoshiSumitomo Pharma Co. Ltd. - Osaka - Japan.ORCID http://orcid.org/0000-0002-4509-2346
Takao KurodaSumitomo Pharma Co. Ltd. - Osaka - Japan.ORCID http://orcid.org/0000-0003-3672-7896
Makoto InoueSumitomo Pharma Co. Ltd. - Osaka - Japan.ORCID http://orcid.org/0000-0003-0804-7439
Eiji KobayashiThe Jikei University School of Medicine - Department of Kidney Regenerative Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0001-8617-3778
Takashi YokooThe Jikei University School of Medicine - Division of Nephrology and Hypertension - Department of Internal Medicine - Tokyo - Japan.ORCID http://orcid.org/0000-0003-1838-7998

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo detail a technique to implant a double-lumen catheter to remove anti-pig antibodies. We transplanted fetal pig kidneys into cynomolgus monkeys using a double filtration plasma exchange (DFPP) protocol.

methodsTwo approaches for double-lumen catheter insertion in monkeys (3-9.2 kg) were developed. DFPP was performed using hydroxyethyl starch (6%) as a replacement fluid. We transplanted fetal porcine kidneys, administered immunosuppressive agents, and evaluated the grafts.

resultsThe catheter insertion site was large, with postoperative hemostasis similar to blind subcutaneous puncture. Monkeys tolerated DFPP well, maintaining stable blood pressure. The technique reduced anti-pig antibodies by 67%, though acute rejection was not fully suppressed.

conclusionA safe technique for double-lumen catheter placement in cynomolgus monkeys was developed, along with a DFPP protocol for reducing anti-pig antibodies.

Indexed as

Kidney TransplantationPlasmapheresisAnimalsFemaleGraft RejectionImmunosuppressive AgentsMacaca fascicularisPilot ProjectsSwineImmunosuppressive Agents

Identifiers

PMID40699129
PMCPMC12273875

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.